Opus Genetics, Inc. (IRD)
NASDAQ: IRD · Real-Time Price · USD
3.810
+0.030 (0.79%)
Aug 6, 2026, 9:43 AM EDT - Market open
Opus Genetics Market Cap
Opus Genetics has a market cap or net worth of $314.58 million as of August 6, 2026. Its market cap has increased by 375.02% in one year.
Market Cap
314.58M
Enterprise Value
253.34M
1-Year Change
375.02%
Ranking
Category
Stock Price
$3.81
ChartMarket Cap Chart
Since November 6, 2020, Opus Genetics's market cap has increased from $21.26M to $314.58M, an increase of 1,379.49%. That is a compound annual growth rate of 59.76%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 6, 2026 | 314.58M | 126.94% |
| Dec 31, 2025 | 138.62M | 268.99% |
| Dec 31, 2024 | 37.57M | -44.87% |
| Dec 29, 2023 | 68.14M | -7.23% |
| Dec 30, 2022 | 73.45M | 13.82% |
| Dec 31, 2021 | 64.53M | -8.29% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 6, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Clinuvel Pharmaceuticals | 333.34M |
| Vicore Pharma Holding AB | 331.75M |
| Lyell Immunopharma | 329.58M |
| Vanda Pharmaceuticals | 306.09M |
| Fate Therapeutics | 303.05M |
| Neumora Therapeutics | 298.31M |
| Anavex Life Sciences | 296.55M |
| OmniAb | 294.29M |